Lianke Liu - Concepedia

Author

Lianke Liu

Nanjing Medical University ORCID

Also Known As

LIU Lian-ke, Lian-Ke Liu, Lian-ke Liu, Lianke Liu, Liu Lianke

Publications

911

Citations

H-Index

Concepts

All Affiliations

Nanjing Medical University Jiangsu Province Hospital Southeast University State Key Laboratory of Digital Medical Engineering Second Affiliated Hospital of Nanjing Medical University

About

Lianke Liu is an author at Nanjing Medical University specializing in medicine, cancer research, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	156
2	Engineering	2	2	91
3	Biomedical Engineering	1	1	45
4	Cell Biology	1	1	37
5	Chemical Engineering	1	1	46

Lianke Liu

Publications

836

Citations

H-Index

Page 1

	Year	Citations
Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial Zhihao Lü, Junye Wang, Yongqian Shu, BMJ	2022	438
MiR‐326/Sp1/KLF3: A novel regulatory axis in lung cancer progression Rong Wang, Jiali Xu, Jing Xu, Cell Proliferation	2018	63
Achieving high-purity colloidal gold nanoprisms and their application as biosensing platforms Zhirui Guo, Xu Fan, Lianke Liu, Journal of Colloid and Interface Science NanoparticlesChemical EngineeringBiosensing PlatformsEngineeringBiosensing Systems	2010	46
Silver nanocrystals sensitize magnetic-nanoparticle-mediated thermo-induced killing of cancer cells Lianke Liu, Fang Ni, Jianchao Zhang, Acta Biochimica et Biophysica Sinica NanoparticlesNanomedicineNanotherapeuticsMagnetic NanoparticlesGlioma	2011	45
Reduced miR-31 and let-7 maintain the balance between differentiation and quiescence in lung cancer stem-like side population cells Hua Shen, Xiaotao Xu, Renhua Guo, Biomedicine & Pharmacotherapy Developmental BiologyMedicineStem Cell ResearchCellular SenescenceCancer Biology	2012	37
Effects of cytokine-induced killer cell treatment in colorectal cancer patients: A retrospective study Jinying Zhang, Lingjun Zhu, Qian Zhang, Biomedicine & Pharmacotherapy InflammationRetrospective StudyCytokineCancer ImmunosurveillanceMedicine	2014	35
Reduction of plasma MicroRNA-21 is associated with chemotherapeutic response in patients with non-small cell lung cancer Juan Wei, Lianke Liu, Wen Gao, Chinese Journal of Cancer Research	2011	28
Microarray expression profiling and bioinformatics analysis of circular RNA expression in lung squamous cell carcinoma. Jiali Xu, Yongqian Shu, Tongpeng Xu, PubMed	2018	28
Autologous cytokine-induced killer cell therapy in lung cancer patients: A retrospective study Jinying Zhang, Lingjun Zhu, Haina Du, Biomedicine & Pharmacotherapy Retrospective StudyRadiation OncologyCancer ImmunosurveillanceMedicineImmunology	2014	25
Bevacizumab biosimilar LY01008 compared with bevacizumab (Avastin) as first‐line treatment for Chinese patients with unresectable, metastatic, or recurrent non‐squamous non–small‐cell lung cancer: A multicenter, randomized, double‐blinded, phase III trial Yuankai Shi, Kaijian Lei, Yuming Jia, Cancer Communications	2021	25

Page 1